Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8613 USD | +5.81% | -3.08% | +68.88% |
05-06 | Oppenheimer Upgrades Chemomab Therapeutics to Outperform | MT |
04-10 | Transcript : Chemomab Therapeutics Ltd. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+68.88% | 11.56M | |
+4.00% | 111B | |
+11.38% | 105B | |
-12.84% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.16% | 16.96B | |
+2.48% | 13.7B | |
+35.94% | 12.45B |
- Stock Market
- Equities
- CMMB Stock
- News Chemomab Therapeutics Ltd.
- Oppenheimer Adjusts Chemomab Therapeutics Price Target to $7 From $12, Maintains Outperform Rating